Federica Prati

Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE‐1 and GSK‐3β Inhibitors

Federica Prati, Angela De Simone, Paola Bisignano et al. · Angewandte Chemie International Edition · 2014 · 122 citations · Full text

Good Brain Permeability, Neurochemical Biomarkers, Pharmaceutical Chemistry +23

Naphthoquinone Derivatives Exert Their Antitrypanosomal Activity via a Multi-Target Mechanism

Jurgen R. Haanstra, Muriel Mazet, Remo Perozzo et al. · PLoS neglected tropical diseases · 2013 · 105 citations · Full text

Novel 8‐Hydroxyquinoline Derivatives as Multitarget Compounds for the Treatment of Alzheimer′s Disease

Federica Prati, Christian Bergamini, Romana Fato et al. · ChemMedChem · 2016 · 84 citations

Blood-brain Barrier Permeability, Neurochemical Biomarkers, Novel 8‐Hydroxyquinoline +19

Two diseases, one approach: multitarget drug discovery in Alzheimer's and neglected tropical diseases

Federica Prati, Elisa Uliassi, María Laura Bolognesi · MedChemComm · 2014 · 75 citations

Promising Therapeutic Approach, Neurodegenerative Diseases, Drug Repositioning +15

3,4-Dihydro-1,3,5-triazin-2(1<i>H</i>)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer’s Disease

Federica Prati, Angela De Simone, Andrea Armirotti et al. · ACS Chemical Neuroscience · 2015 · 66 citations · Full text

Neurochemical Biomarkers, Chemical Biology, Alzheimer ’ +27